These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 33363011)

  • 1. Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer.
    Gong PJ; Shao YC; Yang Y; Song WJ; He X; Zeng YF; Huang SR; Wei L; Zhang JW
    Front Oncol; 2020; 10():578963. PubMed ID: 33363011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer.
    Ma J; Yang D; Ma XX
    Aging (Albany NY); 2021 Jun; 13(12):16287-16315. PubMed ID: 34230220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-methyladenosine methylation-related genes
    Wang Y; Li T; Liu H; Liang Y; Wang G; Fu G; Takatsuki M; Qu H; Jing F; Li J; Jiang M
    Ann Transl Med; 2022 Dec; 10(24):1398. PubMed ID: 36660669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers.
    Li R; Yin YH; Ji XL; Liu X; Li JP; Qu YQ
    Front Mol Biosci; 2021; 8():644620. PubMed ID: 34150845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
    Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
    Front Genet; 2022; 13():872186. PubMed ID: 35937991
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes of N6-methyladenosine modulators promote breast cancer progression.
    Wu L; Wu D; Ning J; Liu W; Zhang D
    BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and Prognostic Characteristics of m
    Zhang B; Gu Y; Jiang G
    Front Genet; 2020; 11():604597. PubMed ID: 33362863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
    Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
    Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RNA m6A writer METTL14 in cancers: Roles, structures, and applications.
    Zhou H; Yin K; Zhang Y; Tian J; Wang S
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188609. PubMed ID: 34375716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
    Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
    Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma.
    Kong F; Wang K; Wang L
    Discov Oncol; 2022 Nov; 13(1):131. PubMed ID: 36434140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival.
    Yang J; Wu Z; Wu X; Chen S; Xia X; Zeng J
    Front Oncol; 2022; 12():1050288. PubMed ID: 36620557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of N6-methyladenosine methylation-related gene signature for predicting the prognosis of hepatocellular carcinoma patients.
    Zheng X; Zhang Y; Wang Y; He Z; Zhang Q; Ren D; Yan X; Yuan X
    Front Surg; 2023; 10():1052100. PubMed ID: 36936652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer.
    Jiang T; Xing L; Zhao L; Ye Z; Yu D; Lin S
    BMC Med Genomics; 2023 May; 16(1):105. PubMed ID: 37194014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of the N6-methyladenosine RNA methylation regulator ZC3H13 as a novel prognostic marker and potential target for hepatocellular carcinoma.
    Wu S; He G; Liu S; Cao Y; Geng C; Pan H
    Int J Med Sci; 2022; 19(4):618-630. PubMed ID: 35582419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer.
    Wang S; Zou X; Chen Y; Cho WC; Zhou X
    Front Genet; 2020; 11():580036. PubMed ID: 33584787
    [No Abstract]   [Full Text] [Related]  

  • 19. Function and clinical significance of N6-methyladenosine in digestive system tumours.
    Huang J; Shao Y; Gu W
    Exp Hematol Oncol; 2021 Jul; 10(1):40. PubMed ID: 34246319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling Analysis of N6-Methyladenosine mRNA Methylation Reveals Differential m6A Patterns during the Embryonic Skeletal Muscle Development of Ducks.
    Chen B; Liu S; Zhang W; Xiong T; Zhou M; Hu X; Mao H; Liu S
    Animals (Basel); 2022 Sep; 12(19):. PubMed ID: 36230334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.